GENÉTICA MOLECULAR EN ONCOHEMATOLOGÍA

Foto de GENÉTICA MOLECULAR EN ONCOHEMATOLOGÍA

Foto de Dana–Farber Cancer Institute

Dana–Farber Cancer Institute

Boston, Estados Unidos

Publicaciones en colaboración con investigadores/as de Dana–Farber Cancer Institute (6)

2024

Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis
American Journal of Hematology

2021

Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
Blood Cancer Journal, Vol. 11, Núm. 7

2020

CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition
Leukemia, Vol. 34, Núm. 6, pp. 1599-1612
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications
International Journal of Cancer, Vol. 147, Núm. 10, pp. 2780-2792

2019

DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains
Experimental Hematology, Vol. 72, pp. 9-13

2016

FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG-stimulated chronic lymphocytic leukemia
American Journal of Hematology, Vol. 91, Núm. 10, pp. 978-983